Technical Analysis for MBRX - Moleculin Biotech, Inc.

Grade Last Price % Change Price Change
grade B 1.15 5.51% 0.06
MBRX closed up 12.37 percent on Friday, May 29, 2020, on 43 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical MBRX trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 5.50%
Wide Bands Range Expansion 5.50%
Oversold Stochastic Weakness 5.50%
Fell Below 200 DMA Bearish 18.56%
1,2,3 Pullback Bullish Bullish Swing Setup 18.56%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 18.56%
Spinning Top Other 18.56%
Stochastic Reached Oversold Weakness 18.56%
Wide Bands Range Expansion 18.56%
Down 3 Days in a Row Weakness 18.56%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas.
Medicine Cancer Pharmaceutical Oncology Chemotherapy Acute Myeloid Leukemia Antineoplastic Drugs Glioblastoma Refractory Acute Myeloid Leukemia

Is MBRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.97
52 Week Low 0.323
Average Volume 7,403,112
200-Day Moving Average 0.97
50-Day Moving Average 0.81
20-Day Moving Average 1.13
10-Day Moving Average 1.10
Average True Range 0.15
ADX 34.52
+DI 31.14
-DI 21.91
Chandelier Exit (Long, 3 ATRs ) 1.52
Chandelier Exit (Short, 3 ATRs ) 0.98
Upper Bollinger Band 1.46
Lower Bollinger Band 0.80
Percent B (%b) 0.43
BandWidth 58.31
MACD Line 0.07
MACD Signal Line 0.10
MACD Histogram -0.0307
Fundamentals Value
Market Cap 22.08 Million
Num Shares 20.3 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -2.32
Price-to-Sales 0.00
Price-to-Book 1.59
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.29
Resistance 3 (R3) 1.27 1.20 1.25
Resistance 2 (R2) 1.20 1.15 1.20 1.24
Resistance 1 (R1) 1.14 1.12 1.17 1.16 1.23
Pivot Point 1.07 1.07 1.08 1.07 1.07
Support 1 (S1) 1.01 1.02 1.04 1.03 0.95
Support 2 (S2) 0.94 0.99 0.94 0.94
Support 3 (S3) 0.88 0.94 0.93
Support 4 (S4) 0.90